Mechanisms of unusual response to lipid-lowering therapy: PCSK9 inhibition
Mingqi Ouyang, Chenyu Li, Die Hu, Daoquan Peng, Bilian Yu
Topics & Concepts
PCSK9Proprotein convertaseMedicineKexinEvolocumabLDL receptorDiseaseMonoclonal antibodyInternal medicineAntibodyLipoproteinImmunologyCholesterolApolipoprotein A1Lipoproteins and Cardiovascular Health